Nightingale

Nightingale was designed as a clinical decision support system aimed at facilitating evidence-based interventions for individuals with autism and related disorders. The company's core mission was to empower service providers with the tools necessary to deliver personalized, high-quality treatment. Recognizing the increasing prevalence of autism, with the CDC reporting 1 in 68 children in the U.S. diagnosed with the condition, Nightingale sought to address the need for effective management and support. While there is no known cure for autism, interventions like applied behavior analysis, speech-language pathology, and occupational therapy can significantly improve symptoms. Nightingale offered a suite of HIPAA-compliant tools for data collection, reporting, and analytics, customizable to various curriculums and settings. The goal was to streamline data management for practitioners, allowing them to dedicate more time to curriculum development and direct client interaction.